Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: A multicenter study

European Journal of Dermatology

Volumn 16, Issue 5, 2006, Pages 553-557

  Tessari, Gianpaolo ^a   Naldi, Luigi ^b   Boschiero, Luigino ^a   Cordiano, Claudio ^a   Piaserico, Stefano ^c   Fortina, Anna Belloni ^c   Cerimele, Decio ^d   La Parola, Ilaria Lesnoni ^e   Capuano, Maria ^f   Gotti, Eliana ^b   Ruggenenti, Piero ^b   Sassi, Fabrizia ^b   Remuzzi, Giuseppe ^b   Girolomoni, Giampiero ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

^e SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^f LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Immunosuppression; Kaposi's sarcoma; Risk factors; Transplant recipients

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; ITALY; KAPOSI SARCOMA; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; COHORT STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SARCOMA, KAPOSI;

EID: 33845335203     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2006.0029     Document Type: Article

References (38)

1. Bécuwe C, Euvrard S, Bosshard S, et al. Maladie de Kaposi et transplantation d'organes: 22 cas. Ann Dermatol Venereol 2005; 132: 839-43.
2. Penn I. Kaposi's sarcoma in transplant recipients. Transplantation 1997; 64: 669-73.
3. Eberhard OK, Kliem V, Brunkhors R. Five cases of Kaposi's sarcoma in kidney graft recipients: possible influence of the immunosuppressive therapy. Transplantation 1999; 67: 180-4.
4. Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M, Monini P. Biology of Kaposi's Sarcoma. Eur J Cancer 2001; 37: 1251-69.
5. Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R. Classic Kaposi's sarcoma. Epidemiology and risk factors. Cancer 2000; 88: 500-17.
6. Geraminejad P, Memar O, Aronson I, Rady PL, Hengge U, Tyring SK. Kaposi's sarcoma and other manifestations of human herpesvirus 8. J Am Acad Dermatol 2002; 47: 641-55.
7. Deborska D, Durlik M, Sadowska A, et al. Human herpesivirus 6 in renal transplant recipients: potential risk factors for the development of human herpesvirus 6 serconversion. Transpl Proc 2003; 35: 2199-201.
8. Ablashi DV, Chatlynne LG, Whitman JE, Cesarman E. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus-8, diseases. Clin Microbiol Rev 2002; 15: 439-64.
9. Deng MC. Cardiac transplantation. Heart 2002; 87: 177-84.
10. th ed. Oxford: Blackwell Scientific Publications, 1994: 175-85.
11. Parkin DM, Whelan SL, Ferlay J. Cancer incidence in five continents. Vol. VII Lyon, France. IARC Sci Publ 1997; 143: 1028.
12. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP. Risk of neoplasia in renal transplant recipients. Lancet 1995; 346: 403.
13. Marsman WA, Van Gelder T, Mulder AH, Ijzermans NM, Zietse R, Weimar W. Succesful treatment of Kaposi's sarcoma in a renal allograft recipient. Nephrol Dial Transplant 1995; 10: 900-1.
14. Farge D. Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Eur J Med 1993; 2: 339-43.
15. Mitxelena J, Gomez-Ullate P, Aguirre A, Rubio G, Lampreabe I, Díaz-Pérez JL. Kaposi's sarcoma in renal transplant patients: experience at the Cruces Hospital in Bilbao. Int J Dermatol 2003; 42: 18-22.
16. Zavos G, Bokos J, Papaconstantinou I, et al. Clinicopathological aspects of 18 Kaposi's sarcoma among 1055 Greek renal transplant recipients. Artif Organs 2004; 28: 595-9.
17. Pedotti P, Cardillo M, Rossini G, et al. Incidence of cancer after kidney transplant: results from the North Italy transplant program. Transplantation 2003; 76: 1448-51.
18. Cardillo M, Rossini G, Scalamogna M, et al. Tumor incidence in heart transplant patients: Report of the North Italy Transplant Program Registry. Transplant Proc 2001; 33: 1840-3.
19. Lesnoni La Parola I, Masini C, Nanni G, Diociauti A, Panocchia N, Cerimele D. Kaposi's sarcoma in renal transplant recipients: experience at the Catholic University in Rome, 1988-1996. Dermatology 1997; 194: 229-33.
20. Serraino D, Piselli P, Angeletti C, et al. Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. Br J Cancer 2005; 92: 572-5.
21. Montagnino G, Lorca E, Tarantino A, et al. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment. Clin Transplant 1996; 10: 461-9.
22. Masuhara M, Ogasawara H, Katyal SL, Nakamura T, Shinozuka H. Cyclosporine stimulates hepatocyte proliferation and accelerates development of hepatocellular carcinomas in rats. Carcinogenesis 1993; 14: 1579-84.
23. Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002; 8: 128-35.
24. Guba M, Graeb C, Jauch KW, Geissler EK. Pro- and anticancer effects of immunosuppressive agents used in organ transplantation. Transplantation 2004; 27: 1777-82.
25. Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93-9.
26. Cattaneo D, Gotti E, Perico N, Bertolini G, Kaiser G, Remuzzi G. Cyclosporine formulation and Kaposi's sarcoma after renal transplantation. Transplantation 2005; 80: 743-8.
27. Farge D, Lebbè C, Marjanovic Z, et al. Human Herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d'Ile de France (GCIF). Transplantation 1999; 67: 1236-42.
28. European mycophenolate mofetil Cooperative Study Group. Placebo controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321-5.
29. Sollinger HW. A blinded randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. US renal transplant Mycophenolate Mofetil study group. Transplantation 1995; 60: 225-32.
30. The tricontinental mycophenolate mofetil study group. A blinded randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029-37.
31. Zhang WK, Wei Li YQ, Yang Y, Lu Y. Safety of mycophenolate mofetil versus azathioprine in renal transplantation. A systematic review. Transplant Proc 2004; 36: 2068-70.
32. Vanrenterghem Y, van Hooff JP, Squifflet JP, et al. European Tacrolimus/MMF Renal Transplantation Study Group. Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. Am J Transplant 2005; 5: 87-95.
33. Kasiske BL, Synder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-13.
34. Gomez E, Aguado S, Rodriguez M, Alvarez Grande J. Kaposi's sarcoma after renal transplantation - disappearance after reduction of immunosuppression and reappearance 7 years later after start of mycophenolate mofetil treatment. Nephrol Dial Transplant 1998; 13: 3279-80.
35. Silva SL, Silva SF, Cavalcante RO, et al. Mycophenolate mofetil attenuates Walker's tumor growth when used alone, but the effect is lost when associated with cyclosporine. Transplant Proc 2004; 36: 1004-6.
36. Andreoni M, Goletti D, Pezzotti P, et al. Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect 2001; 43: 195-9.
37. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's Sacroma in renal transplant recipients. N Engl J Med 2005; 352: 1317-23.
38. Marcelin AG, Roque-Afonso AM, Hurtova M, et al. Fatal disseminated Kaposi's sarcoma following human Herpesvirus 8 primary infections in liver-transplant recipients. Liver Transpl 2004; 10: 295-300.